Incyte
INCY
#1191
Rank
HK$156.99 B
Marketcap
HK$788.84
Share price
-0.47%
Change (1 day)
37.18%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2024: HK$2.47 Billion

According to Incyte's latest financial reports the company's current earnings are HK$4.81 Billion. In 2024 the company made an earning of HK$2.47 Billion a decrease over its 2023 earnings that were of HK$6.52 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2024

Annual earnings

Year Earnings Change
2024HK$2.47 B-62.04%
2023HK$6.52 B57.66%
2022HK$4.13 B-7.24%
2021HK$4.46 B-345.65%
2020-HK$1.82 Billion-147.7%
2019HK$3.80 B322.02%
2018HK$0.90 B-136.94%
2017-HK$2.45 Billion-390.76%
2016HK$0.84 B1322%
2015HK$59.08 M-115.56%
2014-HK$0.38 Billion-41.4%
2013-HK$0.65 Billion87.67%
2012-HK$0.35 Billion-74.9%
2011-HK$1.38 Billion843.59%
2010-HK$0.15 Billion-88.68%
2009-HK$1.29 Billion1.37%
2008-HK$1.28 Billion86.16%
2007-HK$0.69 Billion17.64%
2006-HK$0.59 Billion-28.62%
2005-HK$0.82 Billion-36.1%
2004-HK$1.28 Billion-2.03%
2003-HK$1.3 Billion22.26%
2002-HK$1.07 Billion-27.39%
2001-HK$1.47 Billion198.72%
2000-HK$0.49 Billion132.2%
1999-HK$0.22 Billion-556.86%
1998HK$46.15 M-37.23%
1997HK$73.52 M-259.32%
1996-HK$46.16 Million-45.87%
1995-HK$85.27 Million-9.17%
1994-HK$93.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$127.90 B 929.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$92.70 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$176.02 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.48 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$0.52 B-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$0.36 Billion-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-HK$0.55 Billion-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-HK$0.23 Billion-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$0.44 Billion-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA